Replies to post #5977 on Momenta Pharmaceuticals, Inc. (MNTA)

[acgood]

I believe the $80-90m was the amount of expenses MNTA will have for 2012...so you have to subtract whatever amount of royalties to get the actual cash burn. He did not guide to a number for this part of the equation

[investorgold2002]

Yes that was one of my 2 questions. Disappointing to say the least.
I was excited to see the Bofa analyst had modeled around 50m in expenses for 2012 soon after the Amphastar news. But Shea and wheeler disagree..25m corp G&A also seems excessive for such a small company considering it doesnt include salary for scientists. the excuse is FOB . but never ask them any details on FOB. entire industry is moving at lightening speed on this including doing phase 3 clinical trial(eg: Hospira)...and here these guys seem to be on drawing board. At least tell us some milestones(hide stuff that will aid competition)..